Outcomes of Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19
This cohort study examines the continued use of dexamethasone therapy following discharge in patients with COVID-19.
Related Articles
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer
This study examines the potential benefits of aspirin as adjuvant therapy for survivors of early breast cancer.
CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle
Highly pathogenic avian influenza A(H5N1), also known as H5N1 bird flu, has been circulating among birds and mammals for the past few years. This March,…
Instructions for Authors | JAMA | JAMA Network
Instructions for Authors | JAMA | JAMA Network Instructions for Authors Contact Monica Mungle for help if edits are needed to the top section. Open…
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
This randomized clinical trial investigates the effects of solanezumab and ganterenumab on downstream biomarkers in individuals with dominantly inherited Alzheimer disease.
Introducing JAMA Data Brief
How people consume information is evolving. So is JAMA Medical News. This issue debuts JAMA Data Brief, a new department in the journal’s long-standing Medical…
Morning Glory Syndrome in a Newborn Aged 2 Weeks
This case report describes a diagnosis of morning glory syndrome in a 2-week-old infant who presented with divergent strabismus, cleft lip, and hypertelorism.
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity
This cohort study investigates the cardiovascular disease associations and genetic determinants of epicardial and pericardial adiposity.
Poll: Patients Still Trust Their Physicians the Most
This Medical News article discusses a KFF poll about the public’s exposure to and beliefs about inaccurate health information, as well as media use and…
Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity
This systematic review summarizes the state of the field of functional magnetic resonance imaging (fMRI) drug cue reactivity, assesses their potential for biomarker development, and…
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations
This cohort study uses data from 3 populations to assess whether lipoprotein(a) levels are associated with cardiovascular risk independent of high-sensitivity C-reactive protein level.